SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-025382
Filing Date
2024-06-27
Accepted
2024-06-27 09:34:59
Documents
16
Period of Report
2024-06-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40487
2 ex99-1.htm EX-99.1 17744
3 ex99-1_001.jpg GRAPHIC 7279
  Complete submission text file 0001493152-24-025382.txt   247954

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE gtbp-20240627.xsd EX-101.SCH 3024
5 XBRL LABEL FILE gtbp-20240627_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE gtbp-20240627_pre.xml EX-101.PRE 22365
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3671
Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40023 | Film No.: 241075870
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)